期刊文献+

硝酸甘油雾化吸入控制继发性肺动脉高压临床观察及护理 被引量:2

硝酸甘油雾化吸入控制继发性肺动脉高压临床观察及护理
下载PDF
导出
摘要 目的探讨采用硝酸甘油雾化吸入的护理干预治疗控制先天性心脏病造成继发性肺动脉高压的效果。方法将我科2006年6月~2011年6月收治的226例先心病合并不同程度肺动脉高压的患者随机分为两组,A组为治疗组,采用硝酸甘油雾化吸入;B组为对照组,常规治疗。两组治疗1周后,比较两组患者治疗后肺动脉平均压、体外循环后呼吸机辅助时间、术后氧分压(PaO2)。结果A组肺动脉压控制情况较B组明显有效,两组间疗效差异有显著意义(P<0.05)。结论硝酸甘油雾化吸入用于先心病合并肺动脉高压干预治疗,能取得较好的治疗效果。
作者 滕莉
出处 《护士进修杂志》 2012年第18期1688-1690,共3页 Journal of Nurses Training
关键词 硝酸甘油雾化吸入 先天性心脏病 肺动脉高压 护理 Nitroglycerin aerosol inhalation Congenital heart disease Pulmonary hypertension Nursing
  • 相关文献

参考文献5

二级参考文献27

  • 1陈树宝.儿科学新理论与新技术[M].上海:上海科技教育出版社,1996.111-112.
  • 2Eddahibi S,Humbert M,Sediame S, et al. Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy [ J]. Am J Respir Crit Care Med,2000,162(4 Pt 1) :1493 - 1499.
  • 3Voelkel NF, Tuder RM. CAlular and molecular mechanisms in the pathogenesis of severe pulmonary hypextemion[J]. Eur Respir J,1995,8(12) :2129- 2138.
  • 4Pmtovian C,Adnot S, Eddshlhi S,et al. Heart and lung VEGF mRNA expression in rots with monocrotaline or hypoxia-induced pulmonary hypertension[J]. Am J Physiol, 1998,275(6 Pt 2) :H1948- 1956.
  • 5Michel JB, Ordway GA, Richardson JA, et al. Biphasic induction of immediate early gene expression accompanies activity-dependent angiogenesis and myofiber remodeling of rabbit skeletal muscle[J]. J Clin Invest, 1994,94(1) : 277 - 285.
  • 6Takaoka S, Faul JL, Doyle R. Current therapies for pulmonary arterial hypertension. Semin Cardiothorac Vasc Anesth, 2007, 11:137-148.
  • 7Barst R J, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med, 1996, 334:296-302.
  • 8Mclaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation, 2002, 106 : 1477-1482.
  • 9Lammers AE, Hislop AA, Flynn Y, et al. Epoprostenol treatment in children with severe pulmonary hypertension. Heart, 2007, 93: 739-743.
  • 10Rubenfire M, McLaughlin VV, Allen RP, et al. Transition from intravenous epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial. Chest, In press 2007.

共引文献27

同被引文献7

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部